bioRxivBioengineeringPreprint
Modeling of Nano-carriers for Vascular-targeted Delivery for Blood Clots Treatment
Abstract
Nanoparticles have become one of the emerging and promising technologies that revolutionized the medical fields future on which has received much attention from the scientific community and researchers. Nanotechnology-based targeted drug delivery has a high capacity for loading large amounts of anticoagulants drug to dissolve clots in a safe manner without affecting healthy blood vessels. This paper seeks to provide a better understanding of both the anticoagulant drug release process and the coagulation eliminating process by simulating each process using chemical reaction engineering, moving mesh, and convection-diffusion equation modules. This study adds to a growing corpus of research showing that nanotechnology empowers in treating blood clots within 2-4 hours. In addition, these results cast a new light on a better understanding of the anticoagulation drug diffusion from both spheres and multiply-twinned nanoparticles besides the reduction of clots growth and how it dissolved over time.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Effect of Circadian Rhythm Modulated Blood Flow on Nanoparticle based Targeted Drug Delivery in Virtual In Vivo Arterial Geometries
Shoaib A. Goraya, Shengzhe Ding, … Arif Masud·Brain MultiphysicsPeer-reviewed·Dec 1, 2024
- Design and Evaluation of PLGA-Based Nanocarriers for Targeted and Sustained Drug Delivery in Vascular Disorders
Michael T. Lawson, Emily J. Carter, … Jamie Turner·bioRxiv·Sep 1, 2025
- Dual-Functional Biomimetic Nanoclusters for Sustained Antifibrotic Therapy and Vascular Protection in Fibrosis Management
Rafael A. Monteiro, Camila S. Oliveira, … Pedro H. Carvalho·bioRxiv·Sep 9, 2025
- Potassium ferric oxalate nanoparticles prevent human blood clotting and thrombosis in a mouse model
Devyani Yenurkar, Ankit Choudhary, … Sudip Mukherjee·ACS Applied Materials & InterfacesPeer-reviewed·Apr 30, 2025
- Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen
D. Disharoon, B. G. Trewyn, … K. B. Neeves·bioRxiv·May 5, 2021
- Development of supramolecular anticoagulants with on-demand reversibility
M. Dockerill, D. J. Ford, … N. Winssinger·bioRxiv·Nov 12, 2023